She put the phone on my desk, screen up, before she even sat down. A brochure, all soft light and glass pods, from one of the new longevity lounges that have opened around town this year. A friend had booked her a taster, and she was holding a quote for a package of forty sessions in a pressurised oxygen chamber. She is a composite, drawn from several people I have seen this year rather than any one patient, but the conversation is real enough. The number on the quote was not small. "It says it reverses your cellular age," she told me, a woman in her late fifties, sharp, not gullible. "It shows telomeres getting longer. Is that real, or am I about to spend a lot of money breathing air?"
It is a fair question, and this month it is landing on a lot of people at once. Fortune ran a piece on 8 July 2026 about the longevity boom arriving in an older, richer Asia, and Singapore is at the centre of it. Hyperbaric oxygen, once a hospital treatment you only met if you had a diving injury or a wound that would not heal, is now sold beside cryotherapy and red light in wellness suites. So here is the honest question worth answering, the one my patient actually asked: does climbing into an oxygen chamber slow down ageing, and is the evidence strong enough to justify the price and the risks? Let me walk through what the research really shows.
What Hyperbaric Oxygen Actually Is
Start with the real medicine, because it is real. Hyperbaric oxygen therapy, HBOT, means breathing close to 100 per cent oxygen inside a sealed chamber pressurised well above normal atmospheric pressure, usually around two atmospheres, roughly what you would feel ten metres underwater. At that pressure your blood plasma carries far more dissolved oxygen than usual, and that surplus can be pushed into tissues that are starved of it.
This is genuinely useful for a specific list of problems. The Undersea and Hyperbaric Medical Society, the body that sets the standards, recognises around fourteen approved indications where the evidence is solid (1). These include decompression sickness in divers, carbon monoxide poisoning, gas gangrene, certain non-healing diabetic foot ulcers, tissue damaged by radiotherapy, and skin grafts or flaps that are failing. In those settings HBOT is not wellness. It is a treatment that can save a limb or a life, delivered in a hospital by trained staff. In Singapore it is available in that clinical form and administered by registered professionals. None of what follows is an argument against that.
The question on the brochure is different. It is whether the same chamber, sold to a healthy person, turns back the biological clock.
The Study Everyone Screenshots
Almost every anti-ageing claim for HBOT traces back to one paper. In November 2020, Yafit Hachmo, Amir Hadanny, Shai Efrati and colleagues in Israel published a trial in the journal Aging with a title built for headlines: hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells (2). Telomeres are the protective caps on the ends of your chromosomes that shorten as cells divide and age. Senescent cells are worn-out cells that linger and cause low-grade inflammation. Both are fingerprints of biological ageing.
The researchers took thirty-five healthy adults aged sixty-four and older and put them through an intensive protocol: sixty sessions, five days a week over three months, breathing pure oxygen at two atmospheres for ninety minutes each time. Then they measured immune cells in the blood. Telomere length in several white blood cell types rose by more than twenty per cent, with B cells climbing furthest, and the proportion of senescent T-helper cells fell by around thirty-seven per cent (2). On paper, that looks like ageing running backwards. It is the exact image on my patient's brochure.
So why am I not telling her to book the package?
Why That Headline Is Softer Than It Looks
Read the paper itself, not the press release, and three things change the picture. The authors, to their credit, name all three.
First, there was no control group. Every one of the thirty-five people got the oxygen. There was nobody breathing ordinary air, going through the same daily ritual, the same needle for the same blood tests, to compare against. That matters more than it sounds. Telomere measurement in blood cells is noisy, it drifts with infections, stress and the assay itself, and without a comparison group you cannot tell how much of a twenty per cent swing is treatment and how much is the natural bounce of the test. The authors list "the lack of control group" as a limitation in plain words (2).
Second, the study was small, and smaller than it first appears. Thirty-five were enrolled, but after dropouts and samples that failed quality checks, the telomere result rested on twenty-five people and the senescent-cell result on twenty (2). That is a pilot, a signal worth chasing, not a verdict.
Third, and this is the part the screenshots never carry, look at who ran it. The competing-interests statement is one line: several of the authors work for AVIV Scientific, a commercial hyperbaric company, and Efrati is a shareholder (2). That does not make the data fraudulent, and I want to be careful here. Plenty of good science is done by people with commercial links. But when a single uncontrolled study from a company that sells the therapy is the load-bearing evidence for a claim, the honest reader raises the bar for what comes next, not lowers it.
What Happened When It Was Tested Properly
Here is the update that has not reached the brochures. The way you settle a question like this is a randomised, double-blind, sham-controlled trial, where neither the participants nor the assessors know who got real oxygen and who got a convincing fake, and the real chamber is tested against that fake.
In December 2025, a large one landed in Alzheimer's & Dementia, the field's leading journal (3). Researchers randomised 155 older adults, giving seventy-seven real HBOT and seventy-eight a sham chamber, and followed their thinking, cerebral blood flow and brain glucose metabolism. This was not the longevity claim in its purest form, the participants had type 2 diabetes and early cognitive impairment rather than being perfectly healthy, so read it with that caveat. But it is far bigger and far more rigorous than the 2020 study, and it was designed to catch exactly the placebo effect an uncontrolled trial cannot.
The result was sobering. Both groups improved a little over time, which is what you expect when people come in regularly and get attention. But at three months, the sham group actually edged out the real oxygen group on overall cognition and executive function (3). There was no difference between real and fake in brain blood flow or in brain glucose metabolism on scanning. And on safety, the real-oxygen group had three times as many serious adverse events as the sham group, twenty-five versus eight, spread across different organ systems (3). When the therapy was tested against a proper placebo, the benefit did not just shrink. It disappeared, and the harm signal grew. It is worth adding, in fairness, that Efrati and Hadanny, the authors behind the 2020 telomere study, are also among the authors of this more rigorous null result (3). This is not one camp debunking another. It is the same field's better-designed study landing in a colder place than its early one.
This is the pattern across the field. A 2025 placebo-controlled trial of HBOT for long COVID, published as the HOT-LoCO study, found that both the oxygen group and the sham group improved, which is the clearest possible reminder of how powerful the ritual and expectation of treatment can be (4). Single-arm studies that skip the sham comparison tend to look impressive. Sham-controlled ones tend to deflate.
The Risks Nobody Mentions at the Front Desk
An oxygen chamber is not a facial. Pressurised oxygen is a real intervention with a real side-effect profile, quantified in a 2023 systematic review and meta-analysis of HBOT adverse effects (5). In that pooled analysis of twenty-four trials, side effects turned up in about thirty per cent of people given HBOT versus roughly ten per cent of controls, and they were more frequent once chamber pressure went above two atmospheres (5). The most common problem is barotrauma to the middle ear, the same squeeze you feel on a descending plane but stronger, which can cause pain and, uncommonly, a burst eardrum. Prolonged courses frequently cause temporary short-sightedness, as the oxygen changes the lens of the eye, and while that usually reverses over several weeks it can take a couple of months, and very long courses can accelerate cataracts (5).
Rarer but more serious, high-pressure oxygen can trigger seizures through central nervous system oxygen toxicity, a risk that climbs in people with epilepsy or uncontrolled low blood sugar. There is a lung-injury risk with excessive exposure, and a hard rule that anyone with an untreated collapsed lung must not be put in a chamber. Certain cancer medications, and the older drug disulfiram, interact badly with hyperbaric oxygen. None of this is a reason for panic, and in trained hands with proper screening the complication rate is acceptable (5). It is a reason that this belongs in a medical setting with a doctor who knows your history, not on a wellness menu ordered off a phone.
What This Costs You, and the Thing It Displaces
Then there is the arithmetic my patient was really doing. Singaporeans already live among the longest lives in the world, life expectancy sits around eighty-four, but a good decade of that, on average, is spent in less-than-full health, the gap between how long we live and how long we live well (6). The things that actually close that gap are unglamorous and mostly free. Singapore's own disease burden data puts cardiovascular disease and cancers at the top of the years we lose to death and disability (7), and the levers that move those are the ones nobody can package in a glass pod.
The interventions with the largest, most reliable evidence for adding healthy years are the ones nobody can sell you in a chamber. If you smoke, quit. If you drink, drink less or not at all. Sleep seven to nine hours on a consistent schedule. Move your body daily and lift something heavy twice a week. Eat mostly minimally-processed food with enough protein and fibre. Look after your blood pressure, your blood sugar and your mental health. A treatment layered on top of those foundations is, at best, a small add-on. A treatment bought instead of them, with money and hours that could have gone to a gym membership, better sleep and real food, is a category error. The most expensive thing about an unproven therapy is rarely the price on the quote. It is the attention it pulls away from what works.
The Honest Read
Hyperbaric oxygen is a legitimate, sometimes life-saving treatment for a defined set of medical conditions. As an anti-ageing therapy for healthy people, the evidence is one small, uncontrolled, industry-linked study pointing up, and a larger, rigorous, sham-controlled trial pointing flat, with more side effects in the oxygen group. That is not a balance that justifies forty sessions and a four-figure quote. It might, in time, prove useful for something specific, and I would happily revise this if a large independent sham-controlled trial in healthy adults shows a clear benefit. As of July 2026, that trial does not exist.
What My Patient Went Home With
I did not tell her the chamber was dangerous or a scam, because neither is quite true. I told her what the two studies actually say, side by side, and let the gap between them speak. She asked the question that told me she had understood: "So I would be paying to be the control group they never ran?" More or less, I said. We spent the rest of the consultation on the things her quote could genuinely buy instead, and she left with the brochure back in her bag, unbooked, and a plan for two strength sessions a week that cost her nothing.
If you are weighing a longevity treatment like this, especially if you have ear or sinus problems, lung disease, epilepsy, diabetes, are on chemotherapy, or have any chronic condition, talk it through with your own doctor first. They know your history, your medications and your risks, and whether anything like this makes sense for you is a personal question that a brochure, and a blog, cannot answer.